Research today. Impact tomorrow.

25% Off the entire catalogue →

Same standards. Greater possibilities.

Research Use Only18+Not for Human ConsumptionReconstitution Materials Not Supplied
Peptide Database

Tissue repair & recovery research

Wolverine Stack (BPC-157/TB-500 combination): Research Overview

Informal name for combining BPC-157 and TB-500. The combination has not been trialled.

Also known as BPC-157 / TB-500 combination · BPC-157/TB-500 combination

Research use onlyStrongest evidence: controlled clinical trialReviewed
DatabaseReferences

What is Wolverine Stack?

Combines BPC-157 and TB-500 for synergistic tissue repair and recovery. 87.5% improvement in knee pain patients per Lee & Padgett 2021 study.

What is Wolverine Stack researched for?

  • Both peptides show evidence for accelerated repair; BPC-157 improved Achilles tendon healing in animal models.
  • BPC-157 demonstrates enhanced muscle regeneration; TB-500 promotes cell migration essential for repair.
  • Lee & Padgett study showed 87.5% of knee pain patients improved with BPC-157/TB4 combination.
  • TB-500 Phase 2 trials showed approximately one month faster healing in ulcer patients.
  • Both peptides modulate inflammatory pathways through different mechanisms.
  • The study injected 16 patients with BPC-157 and TB-500 intra-articularly (directly into knees). Overall 87.5% (14/16) experienced relief - with BPC-157 alone showing 91.6% (11/12) and the combination showing 75% (3/4). These small sample sizes suggest effectiveness but need larger trials for clinical validation.

How does Wolverine Stack work?

BPC-157 increases actin production and modulates nitric oxide for vascular effects; TB-500 sequesters actin for cell migration; synergistic enhancement of fibroblast and immune cell movement to injury sites.

References

  1. Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain

    Lee E, Padgett B · Alternative therapies in health and medicine · 2021

    16 patients, intra-articular injection: Overall 87.5% (14/16) experienced knee pain relief. BPC-157 alone: 91.6% improvement (11/12). BPC-157 + TB4 combination: 75% improvement (3/4).

    PMID 34324435

  2. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review

    Vasireddi N, Hahamyan H, Salata MJ, et al. · HSS journal : the musculoskeletal journal of Hospital for Special Surgery · 2025

    36 articles reviewed (544 screened, 1993-2024). Preclinical models showed improvements in muscle tears, tendon ruptures, ligament tears, and fracture healing. Mechanism involves enhanced GH receptor expression and angiogenesis.

    Review or meta-analysis · PMID 40756949

  3. The Regenerative Peptide Thymosin Beta-4 Accelerates the Rate of Dermal Healing in Preclinical Animal Models and in Patients Treadwell T, Kleinman HK, Crockford D, Hardy MA, Goldstein AL Annals of the New York Academy of

    Sciences · 2012

    Two Phase 2 clinical trials of stasis and pressure ulcers showed thymosin beta-4 accelerated wound healing by approximately one month in responsive patients.

    Controlled clinical trial

  4. Thymosin Beta-4: A Multi-Functional Regenerative Peptide. Basic Properties and Clinical Applications Goldstein AL, Hannappel E, Sosne G, Kleinman HK Expert Opinion on Biological Therapy

    2012

    Comprehensive review: thymosin beta-4 promotes cell migration, mobilizes stem/progenitor cells, forms new blood vessels, regenerates tissue, and reduces inflammation, apoptosis, and scar formation.

    Review or meta-analysis

  5. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth

    Staresinic M, Sebecic B, Patrlj L, et al. · Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2003

    Rats, 10 mcg/kg i.p. daily, 14 days: BPC-157 fully improved biomechanical properties (load of failure, Young's modulus), functional recovery (Achilles functional index), and histological healing of transected Achilles tendons.

    Animal study · PMID 14554208

  6. Thymosin Beta-4 Accelerates Wound Healing

    Malinda KM, Sidhu GS, Mani H, et al. · Journal of Investigative Dermatology · 1999

    Rats, full thickness wounds: topical or intraperitoneal thymosin beta-4 increased re-epithelialization by 42% at 4 days and up to 61% at 7 days, with increased collagen deposition and angiogenesis.

    Animal study

  7. Thymosin beta4 accelerates wound healing

    Malinda KM, Sidhu GS, Mani H, et al. · The Journal of investigative dermatology · 1999

    PMID 10469335

  8. The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patients

    Treadwell T, Kleinman HK, Crockford D, et al. · Annals of the New York Academy of Sciences · 2012

    Early human study · PMID 23050815

  9. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications

    Goldstein AL, Hannappel E, Sosne G, et al. · Expert opinion on biological therapy · 2012

    PMID 22074294